Vectors Research Management’s Evolent Health EVH Stock Holding History

Vectors Research Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-350	Closed	-$11K	–	250
2022 Q2	$11K	Hold	350	–	–	﹤0.01%	349
2022 Q1	$11K	Hold	350	–	–	﹤0.01%	340
2021 Q4	$10K	Hold	350	–	–	﹤0.01%	418
2021 Q3	$11K	Hold	350	–	–	﹤0.01%	355
2021 Q2	$7K	Hold	350	–	–	﹤0.01%	418
2021 Q1	$7K	Hold	350	–	–	﹤0.01%	361
2020 Q4	$6K	Hold	350	–	–	﹤0.01%	360
2020 Q3	$4K	Hold	350	–	–	﹤0.01%	350
2020 Q2	$2K	Hold	350	–	–	﹤0.01%	391
2020 Q1	$2K	Hold	350	–	–	﹤0.01%	426
2019 Q4	$3K	Hold	350	–	–	﹤0.01%	467
2019 Q3	$3K	Hold	350	–	–	﹤0.01%	404
2019 Q2	$3K	Hold	350	–	–	﹤0.01%	366
2019 Q1	$4K	Hold	350	–	–	﹤0.01%	338
2018 Q4	$7K	Buy	+350	New	+$8.1K	﹤0.01%	487

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Vectors Research Management's EVH Position: Q3 2022 in Review

Vectors Research Management sold out of Evolent Health (EVH) in Q3 2022, closing a stake of 350 shares — an estimated $11K sold.

Vectors Research Management first reported a position in EVH in Q4 2018 and held it in 15 quarters. The position peaked at $11K in Q2 2022. 251 funds tracked by Wall St. Rank hold EVH as of Q3 2022.

Vectors Research Management reported no remaining Evolent Health position as of Q3 2022 after selling out during the quarter.
Vectors Research Management sold 350 Evolent Health shares in Q3 2022, an estimated $11K.
Vectors Research Management first reported a position in Evolent Health in Q4 2018 and held it in 15 quarters.
Vectors Research Management's Evolent Health position peaked at $11K in Q2 2022.
251 funds tracked by Wall St. Rank held Evolent Health as of Q3 2022.

Based on Vectors Research Management's 13F filing for Q3 2022, filed 8 Nov 2022.